NanoCellect Biomedical Revenue and Competitors

Claim your profile

Location

$47M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • NanoCellect Biomedical's estimated annual revenue is currently $14.6M per year.(i)
  • NanoCellect Biomedical received $0.2M in venture funding in January 2018.
  • NanoCellect Biomedical's estimated revenue per employee is $155,000
  • NanoCellect Biomedical's total funding is $47M.

Employee Data

  • NanoCellect Biomedical has 94 Employees.(i)
  • NanoCellect Biomedical grew their employee count by 19% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.7M619%$53MN/A
#2
$34.3M17717%$110MN/A
#3
$0.4M2735%$236.7MN/A
#4
$34.5M178-5%$160MN/A
#5
$3.7M2420%N/AN/A
#6
$147.3M3212%$192.5MN/A
#7
$17.5M113-3%$24.1MN/A
#8
$2.7M4379%N/AN/A
#9
$34.1M220100%N/AN/A
#10
$47.1M304-3%N/AN/A

NanoCellect's mission is to facilitate breakthrough biomedical discoveries by making cell analysis and sorting technology more portable, affordable, and easier to use. We use microfluidics to make flow cytometers that enable biomedical scientists to analyze and sort cells required for drug discovery, diagnostics, or basic research. NanoCellect's game changing technology offers unique solutions to barriers imposed by current state of the art flow cytometers. We use microfluidics with an integrated sorting system that immensely simplifies the process of analyzing and sorting distinct populations of cells from a heterogeneous population.

keywords:Biotechnology,Cleantech,Hardware,Healthcare,Medical Devices,Medical Diagnostics,Pharmaceuticals,Wind Power

$47M

Total Funding

94

Number of Employees

$14.6M

Revenue (est)

19%

Employee Growth %

N/A

Valuation

N/A

Accelerator

NanoCellect Biomedical News

2022-04-06 - Global Flow Cytometry Services Market Report 2022-2035 ...

... Molecular MD; Molecular Pathology Laboratory Network; Myriad RBM; Namocell; NanoCellect Biomedical; NanoFCM; NeoGenomics Laboratories...

2021-10-25 - NanoCellect Raises $35M

Photo Courtesy of NanoCellect The proceeds from NanoCellect’s $35 million funding rounds will support the development and launch of its second-generation WOLF G2 cell sorting system. NanoCellect Biomedical, Inc. brought in $35 million in Series C and D funding to advance its microfluidic cell so ...

2021-09-16 - NanoCellect accelerates growth plans with close of $35 Million in Series C & D Rounds led by Vertical Venture Partners and Warburg Pincus

SAN DIEGO, Calif., Sept. 16, 2021 /PRNewswire/ -- NanoCellect Biomedical Inc. ("NanoCellect"), the market-leading provider of microfluidic cell sorting solutions to advance cellular discoveries announced the close of $35M of financing to further accelerate commercial growth plans and new produ ...

2021-05-13 - NanoCellect Biomedical Reinvents the Cell Sorter with the WOLF G2

SAN DIEGO, May 13, 2021 /PRNewswire/ -- NanoCellect Biomedical, a leader in the development of cell sorting, announces the virtual launch, scheduled for May 18, 2021, of the WOLF G2 Cell Sorter, the newest addition to NanoCellect's family of products. The WOLF G2 features simple and sterile ce ...

2019-09-03 - Cell sorter, dispenser for gene editing

NanoCellect Biomedical's WOLF Cell Sorter enables users to sort cells with greater confidence that the cells will survive. The Cell Sorter does ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14.6M9413%$331.8M
#2
$28.9M9416%N/A
#3
$23.9M947%N/A
#4
$14.6M94-5%$71M
#5
$23.9M94-1%N/A

NanoCellect Biomedical Funding

DateAmountRoundLead InvestorsReference
2015-11-17$0.5MUndisclosedArticle
2016-01-26$1.8MUndisclosedArticle
2017-11-30$10.0MBMultipleArticle
2018-01-15$0.2MUndisclosedHighlander Venture FundArticle